

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.08516091 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.81047354 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.81047354 |
| 4 | negative T cell selection (GO:0043383) | 5.38856993 |
| 5 | negative thymic T cell selection (GO:0045060) | 5.23547307 |
| 6 | leukocyte aggregation (GO:0070486) | 5.14157725 |
| 7 | interferon-gamma production (GO:0032609) | 5.11829496 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.11088671 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11088671 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.10956717 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00320774 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.91277257 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.78870733 |
| 14 | T cell migration (GO:0072678) | 4.70996357 |
| 15 | response to interleukin-15 (GO:0070672) | 4.44294067 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.42444984 |
| 17 | thymic T cell selection (GO:0045061) | 4.41502123 |
| 18 | positive T cell selection (GO:0043368) | 4.39113953 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.30225440 |
| 20 | T cell selection (GO:0045058) | 4.14960420 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 4.10969757 |
| 22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.02729053 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92609772 |
| 24 | DNA deamination (GO:0045006) | 3.84004999 |
| 25 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.79434339 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 3.77718732 |
| 27 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.72262072 |
| 28 | activated T cell proliferation (GO:0050798) | 3.66702793 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58040657 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56770084 |
| 31 | T cell costimulation (GO:0031295) | 3.56761560 |
| 32 | lymphocyte costimulation (GO:0031294) | 3.51276589 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50249654 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.50249654 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50249654 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50249654 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50249654 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.50249654 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.48437388 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.47347725 |
| 41 | tolerance induction (GO:0002507) | 3.45727555 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.45557032 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.45476878 |
| 44 | ribosomal small subunit assembly (GO:0000028) | 3.43309175 |
| 45 | mast cell activation (GO:0045576) | 3.41625155 |
| 46 | positive regulation of isotype switching (GO:0045830) | 3.39593966 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.38416448 |
| 48 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.37846791 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.33895396 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.31795418 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.28457890 |
| 52 | leukocyte cell-cell adhesion (GO:0007159) | 3.23774115 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22025410 |
| 54 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.21107316 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.20668278 |
| 56 | cytidine metabolic process (GO:0046087) | 3.19855500 |
| 57 | cytidine catabolic process (GO:0006216) | 3.19855500 |
| 58 | cytidine deamination (GO:0009972) | 3.19855500 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.17527046 |
| 60 | regulation of response to interferon-gamma (GO:0060330) | 3.14636929 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14519302 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14519302 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14450465 |
| 64 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.14326237 |
| 65 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12184952 |
| 66 | regulation of memory T cell differentiation (GO:0043380) | 3.11997939 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.10382912 |
| 68 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.09697085 |
| 69 | defense response to protozoan (GO:0042832) | 3.09259814 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09202596 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09180057 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07177459 |
| 73 | sequestering of actin monomers (GO:0042989) | 3.04828415 |
| 74 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.04435543 |
| 75 | positive regulation of cell killing (GO:0031343) | 3.02480736 |
| 76 | negative regulation of adaptive immune response (GO:0002820) | 3.02302308 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01429942 |
| 78 | T cell homeostasis (GO:0043029) | 3.01424961 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.01286865 |
| 80 | detection of bacterium (GO:0016045) | 3.00766045 |
| 81 | regulation of isotype switching (GO:0045191) | 2.99802857 |
| 82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98317548 |
| 83 | positive regulation of interleukin-17 production (GO:0032740) | 2.96543623 |
| 84 | positive regulation of interleukin-2 production (GO:0032743) | 2.96243108 |
| 85 | natural killer cell activation (GO:0030101) | 2.95625329 |
| 86 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.95138003 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94713637 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93600443 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93600443 |
| 90 | detection of other organism (GO:0098543) | 2.92325797 |
| 91 | positive regulation of B cell mediated immunity (GO:0002714) | 2.89419114 |
| 92 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.89419114 |
| 93 | negative regulation of interleukin-12 production (GO:0032695) | 2.88013381 |
| 94 | regulation of T cell mediated immunity (GO:0002709) | 2.87373809 |
| 95 | positive regulation of DNA recombination (GO:0045911) | 2.87106100 |
| 96 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.84652591 |
| 97 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.84652591 |
| 98 | alpha-beta T cell activation (GO:0046631) | 2.83278552 |
| 99 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83153264 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.82863803 |
| 101 | viral transcription (GO:0019083) | 2.82744361 |
| 102 | cellular extravasation (GO:0045123) | 2.82339365 |
| 103 | response to type I interferon (GO:0034340) | 2.81116092 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.78765287 |
| 105 | neutrophil activation (GO:0042119) | 2.77487585 |
| 106 | regulation of B cell mediated immunity (GO:0002712) | 2.76974508 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.76662617 |
| 108 | cellular response to type I interferon (GO:0071357) | 2.76662617 |
| 109 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.76366833 |
| 110 | T cell proliferation (GO:0042098) | 2.75931945 |
| 111 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.75276388 |
| 112 | T cell differentiation (GO:0030217) | 2.75129368 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 2.73616192 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 2.72967750 |
| 115 | myeloid dendritic cell activation (GO:0001773) | 2.70796537 |
| 116 | cellular response to zinc ion (GO:0071294) | 2.70486678 |
| 117 | translational termination (GO:0006415) | 2.70303289 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 2.70224911 |
| 119 | mast cell degranulation (GO:0043303) | 2.70224911 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.69400657 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69353634 |
| 122 | regulation of alpha-beta T cell activation (GO:0046634) | 2.68386504 |
| 123 | response to protozoan (GO:0001562) | 2.67582342 |
| 124 | lymphocyte homeostasis (GO:0002260) | 2.67048706 |
| 125 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.66117894 |
| 126 | lymphocyte migration (GO:0072676) | 2.65983458 |
| 127 | adaptation of signaling pathway (GO:0023058) | 2.65425635 |
| 128 | T cell activation (GO:0042110) | 2.64560400 |
| 129 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64557504 |
| 130 | leukocyte degranulation (GO:0043299) | 2.64276124 |
| 131 | positive regulation of T cell mediated immunity (GO:0002711) | 2.62755528 |
| 132 | respiratory burst (GO:0045730) | 2.62566518 |
| 133 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.61380263 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.61165820 |
| 135 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.60547817 |
| 136 | positive regulation of granulocyte differentiation (GO:0030854) | 2.60168334 |
| 137 | cellular response to interferon-beta (GO:0035458) | 2.59875038 |
| 138 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.59801562 |
| 139 | regulation of cell killing (GO:0031341) | 2.59615721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.81738189 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30278628 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90559051 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.73880820 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53155920 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18332247 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03245929 |
| 8 | * MYC_22102868_ChIP-Seq_BL_Human | 2.95909190 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74546372 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73037374 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70509880 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68334443 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55403491 |
| 14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54874980 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.52586779 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48100346 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47885449 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39548663 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.34763545 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32649648 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32053813 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31468134 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.31203095 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.22790459 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.20363885 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19100176 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.16397168 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14204981 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11820687 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05335568 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04073925 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00098743 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.93749400 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91653253 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90804996 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.89837160 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89749517 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89453939 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.87850610 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82505683 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.79873294 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74990862 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73740801 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.73218893 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73162740 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.69686435 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67980106 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61634280 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60265573 |
| 50 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57575708 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56978171 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55979976 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55178477 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55075376 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.53913699 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51037353 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50982464 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50592049 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48229985 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46641292 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.45152077 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44776924 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44295703 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41187196 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38499194 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38101354 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35769908 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34549071 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33359106 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31931656 |
| 71 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31848194 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31214640 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28435497 |
| 74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27120181 |
| 75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26507767 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.25695838 |
| 77 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25638786 |
| 78 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22991230 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22716653 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22409771 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21904228 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21812060 |
| 83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21104891 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18179544 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.16656166 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16091901 |
| 87 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15226273 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12247236 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11538368 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11468667 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11162216 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10580447 |
| 93 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.10230502 |
| 94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09548459 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09437802 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08592663 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08433533 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 1.07551721 |
| 99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06746354 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05818615 |
| 101 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05818615 |
| 102 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05646399 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05487073 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04980945 |
| 105 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04300642 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02811764 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01594855 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 1.01488642 |
| 109 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01384421 |
| 110 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01147604 |
| 111 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01003061 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00269877 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00202371 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00162706 |
| 115 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00022915 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99949342 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99528107 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99305135 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98946203 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97963352 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96037851 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95899410 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95840512 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95216495 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95158697 |
| 126 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.95095327 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94725417 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94712097 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94282856 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93398019 |
| 131 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93178232 |
| 132 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.93059579 |
| 133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91990122 |
| 134 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91492206 |
| 135 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.90814116 |
| 136 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90181293 |
| 137 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.88654599 |
| 138 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88624608 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87512522 |
| 140 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87446355 |
| 141 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.87166330 |
| 142 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87089305 |
| 143 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85353700 |
| 144 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85323564 |
| 145 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85292945 |
| 146 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84841746 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83586382 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83389461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.18689271 |
| 2 | MP0005671_abnormal_response_to | 3.86982628 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.58210479 |
| 4 | MP0000685_abnormal_immune_system | 3.14921222 |
| 5 | MP0001800_abnormal_humoral_immune | 2.95905525 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.88510090 |
| 7 | MP0009785_altered_susceptibility_to | 2.87303514 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.79871378 |
| 9 | MP0003436_decreased_susceptibility_to | 2.79149191 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.74917907 |
| 11 | MP0001819_abnormal_immune_cell | 2.71822565 |
| 12 | MP0002398_abnormal_bone_marrow | 2.69983732 |
| 13 | MP0001790_abnormal_immune_system | 2.69584543 |
| 14 | MP0005387_immune_system_phenotype | 2.69584543 |
| 15 | MP0002723_abnormal_immune_serum | 2.68138798 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.62723223 |
| 17 | MP0005025_abnormal_response_to | 2.62596089 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.58089051 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.55294495 |
| 20 | MP0000716_abnormal_immune_system | 2.36677126 |
| 21 | MP0002405_respiratory_system_inflammati | 2.32749860 |
| 22 | MP0002419_abnormal_innate_immunity | 2.26754182 |
| 23 | MP0002722_abnormal_immune_system | 2.25204489 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.23183219 |
| 25 | MP0001873_stomach_inflammation | 2.22572512 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.20094626 |
| 27 | MP0003724_increased_susceptibility_to | 2.19570783 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.19431026 |
| 29 | MP0002006_tumorigenesis | 2.17823935 |
| 30 | MP0006082_CNS_inflammation | 2.17123061 |
| 31 | MP0003787_abnormal_imprinting | 2.11184563 |
| 32 | MP0003303_peritoneal_inflammation | 2.06415690 |
| 33 | MP0005464_abnormal_platelet_physiology | 2.04392148 |
| 34 | MP0002429_abnormal_blood_cell | 2.02725256 |
| 35 | MP0010155_abnormal_intestine_physiology | 2.02156417 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.89146172 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.87859172 |
| 38 | MP0003866_abnormal_defecation | 1.80561282 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.79741696 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.77906633 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.77744736 |
| 42 | MP0002163_abnormal_gland_morphology | 1.74863302 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.72635896 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.72635896 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.72453347 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.72444201 |
| 47 | MP0004947_skin_inflammation | 1.71800550 |
| 48 | MP0008057_abnormal_DNA_replication | 1.71325953 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.70977375 |
| 50 | MP0000858_altered_metastatic_potential | 1.65339152 |
| 51 | MP0001853_heart_inflammation | 1.64320747 |
| 52 | MP0000490_abnormal_crypts_of | 1.62462960 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.62221837 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.61918324 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.58198876 |
| 56 | MP0010094_abnormal_chromosome_stability | 1.53573639 |
| 57 | MP0002933_joint_inflammation | 1.49661660 |
| 58 | MP0003077_abnormal_cell_cycle | 1.47152482 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.46580659 |
| 60 | MP0003195_calcinosis | 1.45879380 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.36674111 |
| 62 | MP0003448_altered_tumor_morphology | 1.33196519 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.32052573 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.32002632 |
| 65 | MP0005310_abnormal_salivary_gland | 1.30905007 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.28970309 |
| 67 | MP0003111_abnormal_nucleus_morphology | 1.28198035 |
| 68 | MP0009278_abnormal_bone_marrow | 1.26828414 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.26467679 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.26051434 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 1.25482120 |
| 72 | MP0008872_abnormal_physiological_respon | 1.23923124 |
| 73 | MP0008469_abnormal_protein_level | 1.23695679 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.22508128 |
| 75 | MP0004510_myositis | 1.18513435 |
| 76 | MP0002928_abnormal_bile_duct | 1.17593079 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.16137893 |
| 78 | MP0010307_abnormal_tumor_latency | 1.14807992 |
| 79 | MP0008058_abnormal_DNA_repair | 1.12325622 |
| 80 | MP0002132_abnormal_respiratory_system | 1.10855351 |
| 81 | MP0003172_abnormal_lysosome_physiology | 1.06031226 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 1.04561533 |
| 83 | MP0003011_delayed_dark_adaptation | 1.03458542 |
| 84 | MP0002009_preneoplasia | 1.01402894 |
| 85 | MP0008007_abnormal_cellular_replicative | 0.95922517 |
| 86 | MP0004142_abnormal_muscle_tone | 0.95663788 |
| 87 | MP0001851_eye_inflammation | 0.95115097 |
| 88 | MP0002254_reproductive_system_inflammat | 0.92990069 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.90082764 |
| 90 | MP0002102_abnormal_ear_morphology | 0.88668544 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.87861767 |
| 92 | MP0001968_abnormal_touch/_nociception | 0.87226591 |
| 93 | MP0001919_abnormal_reproductive_system | 0.86443622 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.86202769 |
| 95 | MP0003045_fibrosis | 0.82919076 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.81453754 |
| 97 | MP0000313_abnormal_cell_death | 0.80450133 |
| 98 | MP0003646_muscle_fatigue | 0.79200433 |
| 99 | MP0009763_increased_sensitivity_to | 0.79101513 |
| 100 | MP0004381_abnormal_hair_follicle | 0.76369875 |
| 101 | MP0005023_abnormal_wound_healing | 0.75924841 |
| 102 | MP0000343_altered_response_to | 0.75524249 |
| 103 | MP0003252_abnormal_bile_duct | 0.75086071 |
| 104 | MP0002653_abnormal_ependyma_morphology | 0.74568608 |
| 105 | MP0004742_abnormal_vestibular_system | 0.71751687 |
| 106 | MP0000350_abnormal_cell_proliferation | 0.71541268 |
| 107 | MP0002909_abnormal_adrenal_gland | 0.67901548 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.67766467 |
| 109 | MP0009764_decreased_sensitivity_to | 0.67013732 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.66957060 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.64653817 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.64238013 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.64225954 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.63994796 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.62769089 |
| 116 | MP0006072_abnormal_retinal_apoptosis | 0.61761733 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.61564980 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.61557504 |
| 119 | MP0001764_abnormal_homeostasis | 0.61298922 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.60921448 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.60794067 |
| 122 | MP0000427_abnormal_hair_cycle | 0.60310464 |
| 123 | MP0001663_abnormal_digestive_system | 0.60211271 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.59821561 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.59482038 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.59243289 |
| 127 | MP0004883_abnormal_blood_vessel | 0.58480687 |
| 128 | MP0009745_abnormal_behavioral_response | 0.58372348 |
| 129 | MP0005253_abnormal_eye_physiology | 0.58298886 |
| 130 | MP0000371_diluted_coat_color | 0.57390887 |
| 131 | MP0003786_premature_aging | 0.56786494 |
| 132 | MP0001730_embryonic_growth_arrest | 0.54503049 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.54393234 |
| 134 | MP0003191_abnormal_cellular_cholesterol | 0.53111436 |
| 135 | MP0008873_increased_physiological_sensi | 0.50801769 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.49685214 |
| 137 | MP0003828_pulmonary_edema | 0.48155401 |
| 138 | MP0003795_abnormal_bone_structure | 0.48102179 |
| 139 | MP0005621_abnormal_cell_physiology | 0.46714659 |
| 140 | MP0000249_abnormal_blood_vessel | 0.45676923 |
| 141 | MP0009840_abnormal_foam_cell | 0.44484324 |
| 142 | MP0000609_abnormal_liver_physiology | 0.44117730 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.44096211 |
| 144 | MP0005166_decreased_susceptibility_to | 0.43451699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.20009127 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.01360617 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.91630584 |
| 4 | IgM deficiency (HP:0002850) | 4.85439728 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.84190936 |
| 6 | Myositis (HP:0100614) | 4.55776634 |
| 7 | Abnormality of T cells (HP:0002843) | 4.47570331 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.43146172 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.41624899 |
| 10 | Chronic otitis media (HP:0000389) | 4.40771898 |
| 11 | Recurrent viral infections (HP:0004429) | 4.23138781 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.04767949 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.00409758 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.93382650 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 3.89589037 |
| 16 | Nasal polyposis (HP:0100582) | 3.89111099 |
| 17 | Stomatitis (HP:0010280) | 3.84445644 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.75995525 |
| 19 | Thrombocytosis (HP:0001894) | 3.65956577 |
| 20 | Pustule (HP:0200039) | 3.62917175 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.62600609 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.55800851 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.55071059 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.55071059 |
| 25 | Obstructive lung disease (HP:0006536) | 3.49681009 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49681009 |
| 27 | Meningitis (HP:0001287) | 3.48531434 |
| 28 | IgG deficiency (HP:0004315) | 3.38291835 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.36929222 |
| 30 | Eosinophilia (HP:0001880) | 3.31204855 |
| 31 | Abnormality of eosinophils (HP:0001879) | 3.26107313 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.18404722 |
| 33 | Optic neuritis (HP:0100653) | 3.17606650 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 3.17606650 |
| 35 | Abnormality of B cell number (HP:0010975) | 3.16695367 |
| 36 | B lymphocytopenia (HP:0010976) | 3.16695367 |
| 37 | Granulocytopenia (HP:0001913) | 3.15898842 |
| 38 | Leukocytosis (HP:0001974) | 3.10268971 |
| 39 | Lymphopenia (HP:0001888) | 3.05901540 |
| 40 | Recurrent skin infections (HP:0001581) | 3.04012299 |
| 41 | Orchitis (HP:0100796) | 3.03537891 |
| 42 | Thyroiditis (HP:0100646) | 3.00761350 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.99993521 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.97203289 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.96736556 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.95325063 |
| 47 | Vasculitis (HP:0002633) | 2.95298570 |
| 48 | Encephalitis (HP:0002383) | 2.92773909 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.90522222 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.89865986 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.88350570 |
| 52 | Petechiae (HP:0000967) | 2.85648643 |
| 53 | Stomach cancer (HP:0012126) | 2.85399192 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.81955442 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.81866731 |
| 56 | Hemoptysis (HP:0002105) | 2.75979604 |
| 57 | Lymphoma (HP:0002665) | 2.74982158 |
| 58 | Increased IgE level (HP:0003212) | 2.65441457 |
| 59 | Hypochromic anemia (HP:0001931) | 2.65415113 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.64545725 |
| 61 | Chronic diarrhea (HP:0002028) | 2.59254011 |
| 62 | Pancreatic cysts (HP:0001737) | 2.59113418 |
| 63 | Basal cell carcinoma (HP:0002671) | 2.53579489 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.52887973 |
| 65 | Epistaxis (HP:0000421) | 2.50648894 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50340096 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.49134973 |
| 68 | IgA deficiency (HP:0002720) | 2.42545709 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.41658212 |
| 70 | Joint swelling (HP:0001386) | 2.40535237 |
| 71 | Chest pain (HP:0100749) | 2.38861779 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36112486 |
| 73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.31549133 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.31124890 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.30899791 |
| 76 | Cellulitis (HP:0100658) | 2.30462332 |
| 77 | Arterial thrombosis (HP:0004420) | 2.29489995 |
| 78 | Abnormal number of erythroid precursors (HP:0012131) | 2.28989597 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.27168371 |
| 80 | Reticulocytopenia (HP:0001896) | 2.26003515 |
| 81 | Increased IgM level (HP:0003496) | 2.25861120 |
| 82 | Abnormality of the prostate (HP:0008775) | 2.24864196 |
| 83 | Periodontitis (HP:0000704) | 2.23257670 |
| 84 | Bronchitis (HP:0012387) | 2.22116169 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 2.22114557 |
| 86 | Pancreatic fibrosis (HP:0100732) | 2.19004937 |
| 87 | Poikiloderma (HP:0001029) | 2.18736512 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 2.18412131 |
| 89 | Amaurosis fugax (HP:0100576) | 2.17374171 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 2.16559786 |
| 91 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.16436382 |
| 92 | Episodic fever (HP:0001954) | 2.12598301 |
| 93 | Abnormality of the renal cortex (HP:0011035) | 2.11379577 |
| 94 | Gingivitis (HP:0000230) | 2.10880617 |
| 95 | Verrucae (HP:0200043) | 2.09179497 |
| 96 | Papilloma (HP:0012740) | 2.09179497 |
| 97 | Chronic sinusitis (HP:0011109) | 2.08703072 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 2.08652981 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.07728681 |
| 100 | Skin ulcer (HP:0200042) | 2.07542664 |
| 101 | Anorexia (HP:0002039) | 2.07297984 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 2.04973239 |
| 103 | Colitis (HP:0002583) | 2.04565159 |
| 104 | Urticaria (HP:0001025) | 2.03271208 |
| 105 | Gingival bleeding (HP:0000225) | 2.01497925 |
| 106 | Aplastic anemia (HP:0001915) | 2.01293372 |
| 107 | Pulmonary embolism (HP:0002204) | 2.00493693 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.99500336 |
| 109 | Abnormal platelet volume (HP:0011876) | 1.98351426 |
| 110 | Keratitis (HP:0000491) | 1.98161308 |
| 111 | Cheilitis (HP:0100825) | 1.96211140 |
| 112 | Neutropenia (HP:0001875) | 1.92867090 |
| 113 | Gangrene (HP:0100758) | 1.92635660 |
| 114 | Acute hepatic failure (HP:0006554) | 1.92523231 |
| 115 | Impaired platelet aggregation (HP:0003540) | 1.92486700 |
| 116 | Abnormal platelet function (HP:0011869) | 1.92486700 |
| 117 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91174459 |
| 118 | Abnormality of midbrain morphology (HP:0002418) | 1.89121568 |
| 119 | Molar tooth sign on MRI (HP:0002419) | 1.89121568 |
| 120 | Entropion (HP:0000621) | 1.88649807 |
| 121 | Asplenia (HP:0001746) | 1.84609078 |
| 122 | True hermaphroditism (HP:0010459) | 1.82467633 |
| 123 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.82396953 |
| 124 | Nephronophthisis (HP:0000090) | 1.79046116 |
| 125 | Hematochezia (HP:0002573) | 1.78527383 |
| 126 | Constricted visual fields (HP:0001133) | 1.77995424 |
| 127 | Ketoacidosis (HP:0001993) | 1.75737241 |
| 128 | Progressive inability to walk (HP:0002505) | 1.75445399 |
| 129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75151219 |
| 130 | Ketosis (HP:0001946) | 1.72736931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.48021983 |
| 2 | TXK | 4.85521874 |
| 3 | FRK | 3.90335752 |
| 4 | JAK3 | 2.89014840 |
| 5 | ZAP70 | 2.86033609 |
| 6 | ITK | 2.53568028 |
| 7 | TYK2 | 2.49464361 |
| 8 | STK10 | 2.45119218 |
| 9 | IKBKE | 2.41204556 |
| 10 | MAP4K2 | 2.11962855 |
| 11 | BLK | 2.10564766 |
| 12 | GRK6 | 2.09605594 |
| 13 | IRAK4 | 2.08892218 |
| 14 | TEC | 1.99027701 |
| 15 | NME2 | 1.96146988 |
| 16 | BTK | 1.87551586 |
| 17 | TBK1 | 1.81019887 |
| 18 | MAP3K14 | 1.80035123 |
| 19 | EEF2K | 1.76676680 |
| 20 | LCK | 1.76236000 |
| 21 | FGFR4 | 1.75677610 |
| 22 | JAK1 | 1.67137724 |
| 23 | KDR | 1.64680318 |
| 24 | KIT | 1.64670113 |
| 25 | SYK | 1.57314233 |
| 26 | CSK | 1.55556785 |
| 27 | TESK2 | 1.45762636 |
| 28 | ZAK | 1.41398449 |
| 29 | PIM1 | 1.37999924 |
| 30 | HCK | 1.37546449 |
| 31 | FES | 1.35645576 |
| 32 | RPS6KA4 | 1.33058187 |
| 33 | GRK1 | 1.30800224 |
| 34 | FGFR3 | 1.29580734 |
| 35 | CLK1 | 1.28689465 |
| 36 | NLK | 1.26278675 |
| 37 | MAP3K10 | 1.25038395 |
| 38 | PKN2 | 1.24236501 |
| 39 | WNK4 | 1.21796379 |
| 40 | IKBKB | 1.18541137 |
| 41 | CSF1R | 1.17751406 |
| 42 | FLT3 | 1.14287983 |
| 43 | LRRK2 | 1.12369843 |
| 44 | MAPK13 | 1.11301385 |
| 45 | CAMKK2 | 1.10659977 |
| 46 | IRAK1 | 1.09739495 |
| 47 | INSRR | 1.09434689 |
| 48 | IRAK3 | 1.09309857 |
| 49 | NUAK1 | 1.05975149 |
| 50 | NEK2 | 1.03626502 |
| 51 | CDK4 | 1.02448884 |
| 52 | TAOK3 | 0.99203267 |
| 53 | EPHB1 | 0.99001403 |
| 54 | MAP3K13 | 0.98395706 |
| 55 | LYN | 0.98245813 |
| 56 | MST4 | 0.97241684 |
| 57 | MAP2K3 | 0.96531411 |
| 58 | MARK3 | 0.96102424 |
| 59 | OXSR1 | 0.94241973 |
| 60 | PIM2 | 0.92785844 |
| 61 | DAPK2 | 0.91397448 |
| 62 | WNK3 | 0.89697603 |
| 63 | JAK2 | 0.85159979 |
| 64 | CDC7 | 0.84893749 |
| 65 | STK39 | 0.81817577 |
| 66 | PRKCQ | 0.81175351 |
| 67 | STK4 | 0.78992551 |
| 68 | CDK12 | 0.76768770 |
| 69 | BMPR1B | 0.76594479 |
| 70 | PAK3 | 0.74693436 |
| 71 | PINK1 | 0.73192920 |
| 72 | PASK | 0.69877545 |
| 73 | TNK2 | 0.69588223 |
| 74 | PTK2B | 0.67755879 |
| 75 | STK11 | 0.67268273 |
| 76 | SIK2 | 0.66479993 |
| 77 | WEE1 | 0.66394704 |
| 78 | RPS6KB2 | 0.66298043 |
| 79 | MAP3K8 | 0.64690908 |
| 80 | CHUK | 0.64359626 |
| 81 | CAMKK1 | 0.63673604 |
| 82 | TSSK6 | 0.63517100 |
| 83 | TGFBR2 | 0.63213486 |
| 84 | MAP3K12 | 0.63202053 |
| 85 | ATR | 0.63177447 |
| 86 | YES1 | 0.62700917 |
| 87 | BUB1 | 0.62492052 |
| 88 | PIK3CG | 0.61258865 |
| 89 | FGR | 0.59509591 |
| 90 | ALK | 0.59297038 |
| 91 | MUSK | 0.58483320 |
| 92 | VRK1 | 0.56453210 |
| 93 | RAF1 | 0.54574574 |
| 94 | CDK7 | 0.53700447 |
| 95 | EIF2AK1 | 0.52364692 |
| 96 | PRKCH | 0.51557677 |
| 97 | MATK | 0.50903878 |
| 98 | TGFBR1 | 0.50155232 |
| 99 | TRIB3 | 0.50108562 |
| 100 | NTRK3 | 0.49247080 |
| 101 | BMPR2 | 0.48708868 |
| 102 | ACVR1B | 0.48583856 |
| 103 | FGFR2 | 0.48377060 |
| 104 | TRPM7 | 0.48303605 |
| 105 | BCKDK | 0.47543941 |
| 106 | PRKD2 | 0.46992581 |
| 107 | MAP2K2 | 0.45407516 |
| 108 | PRKCZ | 0.43753208 |
| 109 | BRD4 | 0.43475679 |
| 110 | ADRBK1 | 0.42439529 |
| 111 | RPS6KA6 | 0.42144061 |
| 112 | MAP3K4 | 0.41005421 |
| 113 | ADRBK2 | 0.40909853 |
| 114 | PAK4 | 0.40491405 |
| 115 | EIF2AK3 | 0.40234440 |
| 116 | MAPK11 | 0.39951135 |
| 117 | MAPK12 | 0.39845068 |
| 118 | MAP3K1 | 0.39271979 |
| 119 | SCYL2 | 0.39159506 |
| 120 | PDK1 | 0.37915773 |
| 121 | SRPK1 | 0.37229135 |
| 122 | STK24 | 0.36878859 |
| 123 | ERN1 | 0.36711607 |
| 124 | TNIK | 0.36261011 |
| 125 | TTN | 0.36070136 |
| 126 | STK16 | 0.34692372 |
| 127 | TLK1 | 0.34142603 |
| 128 | RPS6KA5 | 0.32656866 |
| 129 | MAPK4 | 0.32634361 |
| 130 | RPS6KC1 | 0.31723967 |
| 131 | RPS6KL1 | 0.31723967 |
| 132 | TAOK1 | 0.31099232 |
| 133 | MAPKAPK2 | 0.30582114 |
| 134 | MAP3K11 | 0.30579185 |
| 135 | MAPK7 | 0.30561133 |
| 136 | HIPK2 | 0.28670521 |
| 137 | SIK3 | 0.28003975 |
| 138 | MAP2K6 | 0.27776858 |
| 139 | RIPK4 | 0.27601834 |
| 140 | ABL1 | 0.27153174 |
| 141 | NME1 | 0.25632185 |
| 142 | DYRK2 | 0.25203311 |
| 143 | PRKCI | 0.24767255 |
| 144 | PDPK1 | 0.24387776 |
| 145 | MAP3K7 | 0.23977165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.20135544 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.66339556 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.60118837 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.59974149 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.55479946 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50305456 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.48085610 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.46212450 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30939710 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.20021413 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.19893324 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19433273 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.03447625 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00334847 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87172933 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.82888953 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76949659 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75989511 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75166051 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74370716 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70937159 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64941903 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.61930099 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58137144 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48520060 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48378378 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45962740 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.45852773 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41846397 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31910627 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.29455026 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26389929 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.26130765 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.24081382 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23647402 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22910526 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.22675967 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22651035 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.21834603 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21495856 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21341807 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20603884 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.20022980 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.19878452 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18274228 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17372423 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.16431002 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14204716 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11294262 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05988021 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 1.01804120 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00313137 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99517317 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98597867 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96769228 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96494197 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94074248 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93476223 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.93241573 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.93114039 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92398368 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.92328831 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92169836 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91832025 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.90377741 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.90327135 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.89649885 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88859363 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86616530 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84601200 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84446710 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.83720894 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.83665015 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83207741 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83197580 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82770640 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82684202 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81771228 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81498432 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80685547 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.80244325 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80071614 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79221330 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79120032 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77010144 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75733148 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72595312 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.72464261 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71217309 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.70999546 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69946627 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69740806 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65574144 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64989292 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63939002 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63671322 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59908252 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59128371 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57419099 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57124862 |
| 101 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56423842 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55818333 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55105858 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55058332 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54671935 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54350440 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53441095 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52220964 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51646362 |
| 110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50731750 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50672533 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49717096 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49313733 |
| 114 | Protein export_Homo sapiens_hsa03060 | 0.48516296 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48384106 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44184382 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41555620 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40354341 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40090560 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.40084606 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39546491 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.38924457 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38329581 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36795006 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36463885 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32237617 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32025643 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.31991001 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.31774686 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31613925 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29907789 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29747161 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29376236 |
| 134 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29213434 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27960144 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25871477 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25442007 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25245552 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25222658 |
| 140 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24911590 |
| 141 | Morphine addiction_Homo sapiens_hsa05032 | 0.24774159 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24413378 |

